Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community

NCT06940414 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1890

Last updated 2025-07-11

No results posted yet for this study

Summary

The goal of this observational study is to investigate the prevalence and risk factors of hyperkalemia in community-based non-dialysis chronic kidney disease (CKD) patients. The main questions it aims to answer are:

1. What is the prevalence of hyperkalemia in non-dialysis CKD patients in a primary care setting?
2. What are the key risk factors influencing the occurrence of hyperkalemia in this population? Researchers will collect clinical and demographic data from participants across 18 community health centers and use both point-of-care testing (POCT) and laboratory-based methods to measure serum potassium levels and related parameters.

Participants will:

1. Provide blood samples for POCT and laboratory testing.
2. Participate in interviews or questionnaires to gather clinical and lifestyle information.

The findings will be used to construct a risk prediction model for hyperkalemia, aiming to optimize screening pathways and improve disease management strategies in primary care.

Conditions

  • Hyperkalemia
  • Chronic Kidney Disease(CKD)

Interventions

OTHER

No Intervention

This is an observational study with no interventions. POCT devices, provided by Eaglenos Sciences, Inc., are used to measure blood glucose, creatinine, uric acid, hemoglobin, and potassium levels in non-dialysis CKD patients for data collection purposes only.

Sponsors & Collaborators

  • Xiujuan Zang

    lead OTHER_GOV

Principal Investigators

  • Xiujuan Zang, MD · Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-28
Primary Completion
2025-07-31
Completion
2025-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06940414 on ClinicalTrials.gov